glp 1/gip The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Frontiers | Clinical perspectives on

A number of studies have demonstrated sustained weight loss post-medication removal

Additionally, weight loss with semaglutide was associated with improvements in cardiovascular risk factors and physical fitness

may be used until expiration date if kept in the refrigerator If stored at room temperature up to 30C (86F), throw away after 30 days After opening (in-use) Store in the original carton in the refrigerator at 2C to 8C (36F to 46F) or at room temperature up to 30C (86F) Throw away after a total of 30 days at room temperature, 30 days after first use, or after taking 4 weekly doses (whichever occurs first), even if there is medicine left in it LONG-TERM SAFETY Zepbound was FDA-approved in 2023

Both promised convenience, medical oversight, and real results, but I wanted to see which one actually delivered on those claims